Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.90B | 19.11B | 17.93B | 34.54B | 22.27B | 12.77B |
Gross Profit | 3.38B | 3.25B | 4.96B | 18.09B | 9.82B | 1.79B |
EBITDA | 5.17B | 5.01B | 5.20B | 19.29B | 10.83B | 2.58B |
Net Income | 2.53B | 2.39B | 2.94B | 17.03B | 9.07B | 926.80M |
Balance Sheet | ||||||
Total Assets | 32.86B | 33.62B | 29.01B | 38.69B | 26.71B | 15.18B |
Cash, Cash Equivalents and Short-Term Investments | 7.73B | 7.57B | 7.65B | 18.08B | 7.75B | 667.90M |
Total Debt | 6.46B | 6.61B | 5.03B | 5.44B | 5.50B | 5.14B |
Total Liabilities | 12.46B | 12.89B | 10.25B | 10.78B | 10.55B | 8.46B |
Stockholders Equity | 20.34B | 20.65B | 18.69B | 27.89B | 16.15B | 6.71B |
Cash Flow | ||||||
Free Cash Flow | 2.53B | 2.20B | 3.26B | 18.06B | 9.16B | 2.36B |
Operating Cash Flow | 4.98B | 4.36B | 4.97B | 19.50B | 10.41B | 2.90B |
Investing Cash Flow | -2.27B | -1.98B | -1.65B | -4.07B | -1.23B | -477.60M |
Financing Cash Flow | -3.09B | -3.08B | -12.18B | -8.23B | -2.48B | -2.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €11.99B | 128.91 | 10.95% | 0.48% | 25.46% | 41.26% | |
75 Outperform | €1.13B | 13.05 | 9.13% | 1.92% | 1.39% | 13.98% | |
73 Outperform | €684.20M | 10.62 | 17.80% | 5.33% | 14.70% | -18.62% | |
67 Neutral | €22.41B | 8.85 | 12.73% | 5.55% | 20.11% | 89.15% | |
66 Neutral | €1.77B | 52.89 | 5.42% | 0.89% | 15.53% | 112.91% | |
65 Neutral | $10.75B | 15.72 | 5.20% | 1.90% | 3.09% | -27.42% |